Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Free Cash Flow Generation Index
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Free Cash Flow Generation Index of -0.89x as of December 2023. Free cash flow of CN¥-33.12 Million represents -1% of operating cash flow (CN¥37.03 Million). Explore Shandong Keyuan Pharmaceutical Co. Ltd. (301281) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shandong Keyuan Pharmaceutical Co. Ltd. A Free Cash Flow Generation Index (2021–2023)
Historical FCF Generation Index trend for Shandong Keyuan Pharmaceutical Co. Ltd. A across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Shandong Keyuan Pharmaceutical Co. Ltd. .
Annual Free Cash Flow Generation for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)
Year-by-year Free Cash Flow Generation Index for Shandong Keyuan Pharmaceutical Co. Ltd. A. Check cash flow reinvestment rate of Shandong Keyuan Pharmaceutical Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.89x | CN¥-33.12 Million | CN¥37.03 Million | CN¥70.15 Million | ▼ -222.3% |
| 2022 | 0.73x | CN¥84.75 Million | CN¥115.86 Million | CN¥31.11 Million | ▲ +19.6% |
| 2021 | 0.61x | CN¥31.83 Million | CN¥52.02 Million | CN¥20.19 Million | — |